A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is 8 334,25 ₴, with a 24-hour trading volume of 14,19B ₴. The asset's market cap is 12,92T ₴, after moving -1.63% in the last day.
Tokenized AstraZeneca PLC is trading at 4 240,15 ₴, with a tokenized market cap of 580,84M ₴ and a 24-hour trading volume of 32,69M ₴. The tokenized asset has moved -1.70% in the past 24 hours.